These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20648509)

  • 1. Proof of RNA interference in humans after systemic delivery of siRNAs.
    Kurreck J
    Angew Chem Int Ed Engl; 2010 Aug; 49(36):6258-9. PubMed ID: 20648509
    [No Abstract]   [Full Text] [Related]  

  • 2. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic.
    Davis ME
    Mol Pharm; 2009; 6(3):659-68. PubMed ID: 19267452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery.
    Bellocq NC; Pun SH; Jensen GS; Davis ME
    Bioconjug Chem; 2003; 14(6):1122-32. PubMed ID: 14624625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference advances to early-stage clinical trials.
    Brower V
    J Natl Cancer Inst; 2010 Oct; 102(19):1459-61. PubMed ID: 20870977
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo delivery of RNAi with lipid-based nanoparticles.
    Huang L; Liu Y
    Annu Rev Biomed Eng; 2011 Aug; 13():507-30. PubMed ID: 21639780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.
    Bartlett DW; Davis ME
    Bioconjug Chem; 2007; 18(2):456-68. PubMed ID: 17326672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery.
    Meyer M; Philipp A; Oskuee R; Schmidt C; Wagner E
    J Am Chem Soc; 2008 Mar; 130(11):3272-3. PubMed ID: 18288843
    [No Abstract]   [Full Text] [Related]  

  • 9. siRNAs with guts.
    Maclachlan I
    Nat Biotechnol; 2008 Apr; 26(4):403-5. PubMed ID: 18392024
    [No Abstract]   [Full Text] [Related]  

  • 10. Delivery of RNA interference therapeutics using polycation-based nanoparticles.
    Howard KA
    Adv Drug Deliv Rev; 2009 Jul; 61(9):710-20. PubMed ID: 19356738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles.
    Pun SH; Tack F; Bellocq NC; Cheng J; Grubbs BH; Jensen GS; Davis ME; Brewster M; Janicot M; Janssens B; Floren W; Bakker A
    Cancer Biol Ther; 2004 Jul; 3(7):641-50. PubMed ID: 15136766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla.
    Meade BR; Dowdy SF
    Discov Med; 2009 Dec; 8(43):253-6. PubMed ID: 20040280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference: From tools to therapies.
    Baker M
    Nature; 2010 Apr; 464(7292):1225. PubMed ID: 20414309
    [No Abstract]   [Full Text] [Related]  

  • 14. RNAi therapeutics: an update on delivery.
    Nguyen T; Menocal EM; Harborth J; Fruehauf JH
    Curr Opin Mol Ther; 2008 Apr; 10(2):158-67. PubMed ID: 18386228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated iminodiacetic acid zinc complex stabilizes cationic RNA-bearing nanoparticles.
    Levy DE; Ding Z; Hu C; Zalipsky S
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5499-501. PubMed ID: 20696578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic siRNA delivery using biocompatible calcium phosphate nanoparticles.
    Park K
    J Control Release; 2010 Mar; 142(3):295. PubMed ID: 20149829
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.
    Liu B
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):112-9. PubMed ID: 17670766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated nanocarriers for systemic delivery.
    Jain NK; Nahar M
    Methods Mol Biol; 2010; 624():221-34. PubMed ID: 20217599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.